Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107216326A reveals novel tandem catalysis for phenanthridine derivatives. Enables cost reduction and scalable supply for high-purity pharmaceutical intermediates manufacturing.
Novel thiourea-catalyzed asymmetric synthesis of trifluoromethyl bisoxazoles with high ee. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN105523874A reveals a mild catalytic method for 2,2-dihalo-1,3-dicarbonyl derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN111995636A details a novel Ru-catalyzed hydrosilylation route for ortho-hydroxy-nitrogen silanes, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113735926A reveals a high-yield diazotization route for uridine production, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN102276537A details a streamlined 4-step synthesis for 2-cyano-5-aminopyrimidine. Discover cost-effective manufacturing and scalable supply chain solutions for this critical heterocyclic building block.
Patent CN112321535B reveals a novel ketone-based route for Imaric Acid, offering high purity and cost reduction for Imatinib manufacturing supply chains.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN102241614B details a phosphotungstic acid catalyzed method for N-alkyl amides offering significant supply chain stability and cost reduction advantages.
Patent CN106995373B reveals a one-pot synthesis method using ammonium iodide. This breakthrough offers significant supply chain stability and cost reduction advantages.
Patent CN113185419B reveals a greener 4-step route for oxybuprocaine hydrochloride, eliminating genotoxic risks and enabling cost-effective commercial scale-up.
Patent CN114853797B reveals a mild selenium-catalyzed method for alpha-amino boron compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Cs2CO3 catalyzed route offers high yield dihydrofuran intermediates. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Patent CN104591938A reveals high-yield Pd-catalyzed route. Offers supply chain stability and cost efficiency for global pharmaceutical intermediate manufacturing partners.
Novel patent CN107629014A offers mild conditions for triazole intermediate production ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Patent CN107698648B reveals a novel synthesis for cholesterol-naphthalimide hybrids with anticancer and liquid crystal applications, offering scalable routes for high-purity intermediates.
Patent CN1091097C details a safe, high-purity route for N-substituted glycine esters, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.